Phibro Animal Health (NASDAQ:PAHC) Rating Increased to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research report report published on Tuesday.

Several other research analysts have also weighed in on the stock. Barclays upped their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective for the company. Finally, Bank of America upped their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $16.50.

Phibro Animal Health Stock Performance

PAHC opened at $25.06 on Tuesday. The business has a fifty day simple moving average of $22.46 and a 200-day simple moving average of $19.52. The firm has a market cap of $1.01 billion, a PE ratio of 58.28, a P/E/G ratio of 0.58 and a beta of 0.51. The company has a quick ratio of 1.64, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a fifty-two week low of $9.40 and a fifty-two week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. The company had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. As a group, equities analysts predict that Phibro Animal Health will post 1.63 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 1.92%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Insider Activity at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction dated Wednesday, September 4th. The shares were bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares in the company, valued at $500,500. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 50.07% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently modified their holdings of the business. CWM LLC increased its stake in Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the period. nVerses Capital LLC acquired a new position in shares of Phibro Animal Health in the 3rd quarter valued at $70,000. Summit Securities Group LLC bought a new position in shares of Phibro Animal Health during the 2nd quarter worth about $83,000. China Universal Asset Management Co. Ltd. boosted its position in shares of Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after acquiring an additional 1,522 shares in the last quarter. Finally, Illinois Municipal Retirement Fund increased its stake in Phibro Animal Health by 7.2% in the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after acquiring an additional 765 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.